#1 Clinical Trials Search in Europe

Betaxolol

Betaxolol, a beta-blocker medication, has been the subject of several clinical trials focusing on its use in various eye-related conditions. These trials aim to evaluate the safety and efficacy of Betaxolol in treating conditions such as glaucoma, ocular hypertension, and retinopathy of prematurity. The studies explore different formulations of Betaxolol, including eye drops and topical applications, and compare it with other treatments to determine its effectiveness in managing intraocular pressure and preventing disease progression.

Table of Contents

What is Betaxolol?

Betaxolol is a medication primarily used in ophthalmology (eye care) to treat certain eye conditions. It belongs to a class of drugs called beta-blockers, which work by reducing pressure inside the eye[1]. Betaxolol is available in different forms, including eye drops known as BETOPTIC S[1]. It’s important to note that there’s also a variant called Levobetaxolol, which is being studied for similar uses[2].

Medical Conditions Treated

Betaxolol is primarily used to treat the following eye conditions:

  • Open-Angle Glaucoma: This is a type of glaucoma where the drainage angle for eye fluid remains open, but the trabecular meshwork is partially blocked. This leads to a gradual increase in eye pressure[3][2].
  • Ocular Hypertension: This condition is characterized by higher than normal pressure inside the eye, without any detectable changes in vision or damage to the eye structure[1][2].
  • Retinopathy of Prematurity (ROP): This is an eye disorder that primarily affects premature infants. It’s characterized by abnormal blood vessel growth in the retina, the light-sensitive tissue at the back of the eye[4].

How Betaxolol Works

Betaxolol works by reducing the production of aqueous humor, the clear fluid inside the eye. By decreasing fluid production, it helps lower the intraocular pressure (IOP), which is the pressure inside the eye. High IOP is a major risk factor for glaucoma and can damage the optic nerve, leading to vision loss[3]. In the case of retinopathy of prematurity, researchers hypothesize that Betaxolol might help prevent the development of severe cases of the condition[4].

Administration and Dosage

Betaxolol is typically administered as eye drops. The dosage and frequency can vary depending on the specific condition being treated and the formulation used. Here are some general guidelines based on the clinical trials:

  • For glaucoma and ocular hypertension in adults: Usually one drop in the affected eye(s) twice daily, typically in the morning and evening[2].
  • For pediatric patients: The dosage is similar, with drops administered twice daily for 12 weeks in one study[1].
  • For premature infants (in the study for retinopathy of prematurity): The medication was administered twice a day between 32 and 35 weeks gestational age[4].

Always follow your doctor’s instructions regarding dosage and administration.

Clinical Studies

Several clinical trials have been conducted to evaluate the safety and efficacy of Betaxolol:

  1. The Early Manifest Glaucoma Trial (EMGT) compared the effect of immediate therapy to lower intraocular pressure versus late or no treatment on the progression of newly detected open-angle glaucoma[3].
  2. A study in pediatric patients with glaucoma or ocular hypertension evaluated the safety and efficacy of BETOPTIC S (betaxolol) compared to Timolol Gel-forming Solution[1].
  3. A trial in premature infants investigated whether topical betaxolol could reduce the development of severe retinopathy of prematurity[4].
  4. A study in Chinese patients compared Levobetaxolol eye drops to Betaxolol eye drops for treating primary open-angle glaucoma or ocular hypertension[2].

Side Effects

Like all medications, Betaxolol can cause side effects. In the clinical trials, researchers monitored for various side effects, including:

  • Development of apnea (temporary cessation of breathing) and/or bradycardia (slow heart rate) in premature infants[4].
  • Changes in visual acuity (sharpness of vision)[2].
  • Changes in blood pressure and pulse rate[1].

Always report any unusual symptoms or side effects to your healthcare provider.

Special Considerations

Betaxolol has been studied in various populations, including adults, children, and even premature infants. However, its use in specific populations may require special considerations:

  • Pediatric Use: Studies have been conducted to evaluate the safety and efficacy of Betaxolol in children with glaucoma or ocular hypertension[1].
  • Use in Premature Infants: Research has explored the potential of Betaxolol in preventing severe retinopathy of prematurity[4].
  • Long-term Use: Some studies, like the Early Manifest Glaucoma Trial, have followed patients for extended periods (minimum of 4 years) to assess long-term effects and efficacy[3].

Always consult with your healthcare provider for personalized advice and information about using Betaxolol for your specific condition.

Aspect Details
Drug Name Betaxolol (including formulations like BETOPTIC S and Levobetaxolol)
Conditions Studied Open-Angle Glaucoma, Ocular Hypertension, Retinopathy of Prematurity
Administration Methods Eye drops, Topical application
Primary Outcomes Changes in Intraocular Pressure (IOP), Development of side effects
Secondary Outcomes Visual field changes, Retinal nerve fiber layer thickness, Visual acuity
Study Durations Ranging from 8 weeks to 4+ years
Patient Groups Adults with glaucoma or ocular hypertension, Pediatric patients, Premature infants
Comparators Placebo, Timolol, No treatment (in some studies)

FAQ

  • What eye conditions is Betaxolol being studied for in clinical trials? Betaxolol is being studied for several eye conditions, including open-angle glaucoma, ocular hypertension, and retinopathy of prematurity in premature infants.
  • How is Betaxolol typically administered in these trials? In the clinical trials, Betaxolol is usually administered as eye drops or topical applications. For example, in some studies, it's given as BETOPTIC S 0.25% eye drops or Levobetaxolol eye drops, typically applied twice daily.
  • What is the main goal of using Betaxolol in these eye conditions? The main goal of using Betaxolol in these conditions is to lower intraocular pressure (IOP). Reducing IOP is important in managing glaucoma and ocular hypertension, and may help prevent disease progression.
  • Are there any specific side effects being monitored in these Betaxolol trials? Yes, the trials monitor for various side effects. In premature infants, for example, they watch for the development of apnea (pauses in breathing) and bradycardia (slow heart rate). Other studies assess changes in visual acuity, visual field, and retinal nerve fiber layer thickness.
  • How long do these Betaxolol clinical trials typically last? The duration of the trials varies. Some last for a few weeks, such as the 8-week trial comparing Levobetaxolol and Betaxolol eye drops, while others are longer-term studies, like the Early Manifest Glaucoma Trial which followed patients for a minimum of 4 years.

Ongoing Clinical Trials on Betaxolol

  • Study on Glaucoma Treatment: Comparing Brimonidine, Pilocarpine Nitrate, and Brinzolamide in Patients with Newly Diagnosed Open-Angle Glaucoma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Sweden

Glossary

  • Intraocular Pressure (IOP): The fluid pressure inside the eye. Elevated IOP is a major risk factor for glaucoma and is the target of many glaucoma treatments.
  • Open-Angle Glaucoma: A type of glaucoma where the angle between the iris and cornea is open, but the eye's drainage canals become clogged over time, leading to increased eye pressure and potential optic nerve damage.
  • Ocular Hypertension: A condition where the pressure inside the eye (intraocular pressure) is higher than normal, but without detectable changes in vision or damage to the eye structure.
  • Retinopathy of Prematurity (ROP): An eye disorder that primarily affects premature infants, causing abnormal blood vessel growth in the retina, which can lead to vision problems or blindness.
  • Beta Blocker: A class of medications that block the effects of the hormone epinephrine, also known as adrenaline. In eye care, they are used to reduce fluid production in the eye, thereby lowering intraocular pressure.
  • Apnea: A temporary pause in breathing, often occurring in premature infants.
  • Bradycardia: An abnormally slow heart rate, which can be a concern in premature infants.
  • Visual Field: The entire area that can be seen when the eye is focused on a central point. Changes in the visual field can indicate progression of eye conditions like glaucoma.
  • Retinal Nerve Fiber Layer (RNFL): A layer of the retina containing nerve fibers. The thickness of this layer can be an indicator of eye health and is often measured in glaucoma studies.
  • Argon Laser Trabeculoplasty: A laser treatment used to improve drainage of eye fluid in patients with glaucoma, often used in combination with eye drop medications.

References

  1. https://clinicaltrials.gov/study/NCT00061542
  2. https://clinicaltrials.gov/study/NCT02617459
  3. https://clinicaltrials.gov/study/NCT00000132
  4. https://clinicaltrials.gov/study/NCT01660620